The DOI matches its Crossref record.
Hormonal Chemoprevention of Cancer in Women
Abstract
The use of oral contraceptives in the United States during the past three decades has led to a dramatic decline in the incidence of cancers of the ovary and endometrium. The magnitude of these declines was predictable both from epidemiologic data and from the biologic effects of oral contraceptives on these tissues. Although the incidence of breast cancer has not been substantially affected by current oral contraceptives, it may be possible to develop alternative forms of contraception that provide protection against all three cancers. The major goal of hormonal chemoprevention of cancer is to reduce cell proliferation in the relevant epithelial tissue. New chemopreventive agents such as tamoxifen exemplify the application of this principle.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The causes and prevention of cancer.
Ames, B. N., Gold, L. S., & Willett, W. C. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5258 · Cited by 1,319
Jobling, S., Reynolds, T., White, R., Parker, M. G., & Sumpter, J. P. (1995) · Environmental Health Perspectives · doi:10.1289/ehp.95103582 · Cited by 1,259
Human Telomerase and Its Regulation
Cong, Y.-S., Wright, W. E., & Shay, J. W. (2002) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.66.3.407-425.2002 · Cited by 898
Black, L. J., Sato, M., Rowley, E. R., Magee, D. E., Bekele, A., Williams, D. C., Cullinan, G. J., Bendele, R., Kauffman, R. F., & Bensch, W. R. (1994) · Journal of Clinical Investigation · doi:10.1172/jci116985 · Cited by 609
Medical hypothesis: xenoestrogens as preventable causes of breast cancer.
Davis, D. L., Bradlow, H. L., Wolff, M., Woodruff, T., Hoel, D. G., & Anton-Culver, H. (1993) · Environmental Health Perspectives · doi:10.1289/ehp.93101372 · Cited by 533
Is Estradiol a Genotoxic Mutagenic Carcinogen?1
Liehr, J. G. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.1.0386 · Cited by 484
Hereditary breast cancer: Pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage
Marcus, J. N., Watson, P., Page, D. L., Narod, S. A., Lenoir, G. M., Tonin, P., Linder-Stephenson, L., Salerno, G., Conway, T. A., & Lynch, H. T. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960215)77:4<697::aid-cncr16>3.0.co;2-w · Cited by 454
Rebbeck, T. R., Friebel, T., Wagner, T., Lynch, H. T., Garber, J. E., Daly, M. B., Isaacs, C., Olopade, O. I., Neuhausen, S. L., van ′t Veer, L., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2004.00.8151 · Cited by 411
Hormones and the physiological architecture of life history evolution
Finch, C. E., & Rose, M. R. (1995) · The Quarterly Review of Biology · doi:10.1086/418864 · Cited by 376
Negative Interaction between the RelA(p65) Subunit of NF-κB and the Progesterone Receptor
Kalkhoven, E., Wissink, S., van der Saag, P. T., & Burg, B. V. D. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.11.6217 · Cited by 352
Development of the human breast
Russo, J., & Russo, I. H. (2004) · Maturitas · doi:10.1016/j.maturitas.2004.04.011 · Cited by 324
Culture and symptom reporting at menopause
Melby, M. K., Lock, M., & Kaufert, P. (2005) · Human Reproduction Update · doi:10.1093/humupd/dmi018 · Cited by 308
Mechanisms of inhibitors of mutagenesis and carcinogenesis
De Flora, S. (1998) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(97)00292-3 · Cited by 304
Weiderpass, E., Persson, I., Adami, H.-O., Magnusson, C., Lindgren, A., & Baron, J. A. (2000) · Cancer Causes & Control · doi:10.1023/a:1008946825313 · Cited by 273
NONPROSTATIC SOURCES OF PROSTATE-SPECIFIC ANTIGEN
Diamandis, E. P., & Yu, H. (1997) · Urologic Clinics of North America · doi:10.1016/s0094-0143(05)70373-6 · Cited by 172
Surface patterning: Tool to modulate stem cell differentiation in an adipose system
Chaubey, A., Ross, K. J., Leadbetter, R. M., & Burg, K. J. L. (2008) · Journal of Biomedical Materials Research Part B: Applied Biomaterials · doi:10.1002/jbm.b.30846 · Cited by 50
Luo, S., Labrie, C., Bélanger, A., & Labrie, F. (1997) · Endocrinology · doi:10.1210/endo.138.8.5345 · Cited by 34
Metadata
- Authors
- Henderson, B. E., Ross, R. K., & Pike, M. C.
- Venue
- Science
- Published
- 1993-01-29
- Volume
- 259
- Issue
- 5095
- Pages
- 633-638
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1966823049
- Cited by
- 239
- References
- 0
- FWCI
- 11.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.